Please ensure Javascript is enabled for purposes of website accessibility

biotech

May 13, 2020

U.Va. research to inform COVID-19 drug treatment

The University of Virginia School of Medicine announced Tuesday that results from a 2019 U.Va. study are being used to inform a national study looking into the effectiveness of the antidepressant medication fluvoxamine as a potential treatment for COVID-19. Researchers at Washington University School of Medicine in St. Louis say the drug may prevent dangerous […]

Mar 20, 2020

Sterling biotech firm launches COVID-19 test

Sterling-based biotech company Aperiomics has launched a COVID-19 test available for to medical providers nationwide for $250 per sample. Aperiomics says it has the capacity to process and deliver results on 1,000 tests per week. The company says it can turn around results from its Xplore-COVID-19 tests within 48 to 72 hours of receiving a […]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.